USRE33845E - Novel skin tanning composition - Google Patents
Novel skin tanning composition Download PDFInfo
- Publication number
- USRE33845E USRE33845E US07/630,822 US63082290A USRE33845E US RE33845 E USRE33845 E US RE33845E US 63082290 A US63082290 A US 63082290A US RE33845 E USRE33845 E US RE33845E
- Authority
- US
- United States
- Prior art keywords
- weight
- composition
- tyrosine
- amount
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 33
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 27
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 22
- 239000003755 preservative agent Substances 0.000 claims abstract description 21
- 239000012071 phase Substances 0.000 claims abstract description 20
- 239000010690 paraffinic oil Substances 0.000 claims abstract description 17
- 239000008346 aqueous phase Substances 0.000 claims abstract description 16
- 230000002335 preservative effect Effects 0.000 claims abstract description 16
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 15
- 229940101267 panthenol Drugs 0.000 claims abstract description 15
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 15
- 239000011619 pantothenol Substances 0.000 claims abstract description 15
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 14
- 239000000194 fatty acid Substances 0.000 claims abstract description 14
- 229930195729 fatty acid Natural products 0.000 claims abstract description 14
- 229910052901 montmorillonite Inorganic materials 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 10
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 10
- 150000002148 esters Chemical class 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims abstract description 9
- 235000019198 oils Nutrition 0.000 claims abstract description 9
- -1 aliphatic alcohols Chemical class 0.000 claims abstract description 8
- 239000003513 alkali Substances 0.000 claims abstract description 7
- 238000009835 boiling Methods 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- 239000002243 precursor Substances 0.000 claims abstract description 6
- 239000010775 animal oil Substances 0.000 claims abstract description 5
- 150000004670 unsaturated fatty acids Chemical group 0.000 claims abstract description 5
- 239000008158 vegetable oil Substances 0.000 claims abstract description 5
- 241001465754 Metazoa Species 0.000 claims abstract description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000005456 glyceride group Chemical group 0.000 claims abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 4
- 239000001301 oxygen Substances 0.000 claims abstract description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 4
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims abstract description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 229960004441 tyrosine Drugs 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 12
- 150000003626 triacylglycerols Chemical class 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 10
- 239000002304 perfume Substances 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 8
- 235000004866 D-panthenol Nutrition 0.000 claims description 7
- 239000011703 D-panthenol Substances 0.000 claims description 7
- 239000003381 stabilizer Substances 0.000 claims description 7
- 229960003949 dexpanthenol Drugs 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000001540 sodium lactate Substances 0.000 claims description 5
- 229940005581 sodium lactate Drugs 0.000 claims description 5
- 235000011088 sodium lactate Nutrition 0.000 claims description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 3
- 239000005642 Oleic acid Substances 0.000 claims description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- 238000001879 gelation Methods 0.000 claims description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- 235000021313 oleic acid Nutrition 0.000 claims description 3
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 claims description 3
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 claims description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 235000006708 antioxidants Nutrition 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- 125000003798 L-tyrosyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 abstract 1
- 241000499883 Solaria <angiosperm> Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 101150035983 str1 gene Proteins 0.000 abstract 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 5
- 229940042585 tocopherol acetate Drugs 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- 235000008729 phenylalanine Nutrition 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- 241001474374 Blennius Species 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- WUEOWFOHISLOET-QRPNPIFTSA-N CC(C)CO.N[C@@H](CC(C=C1)=CC=C1O)C(O)=O Chemical compound CC(C)CO.N[C@@H](CC(C=C1)=CC=C1O)C(O)=O WUEOWFOHISLOET-QRPNPIFTSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004676 glycans Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108010020344 melanoproteins Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000063 preceeding effect Effects 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000010499 rapseed oil Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- 150000003667 tyrosine derivatives Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
Definitions
- compositions have been proposed for skin tanning over the course of the years. Some of these proposed compositions contain as active main ingredient panthenol which is applied in an acid, non aqueous phase, and are indeed effecting the desired skin tanning after exposure to natural or artificial sunlight.
- panthenol which is applied in an acid, non aqueous phase
- the action is too slow.
- compounds which have to protect the skin temporarily against excessive interaction of harmful frequencies in the light spectrum, leading to burning before the actual skin tanning process due to the natural production of melanoprotein (pigment) has taken place in a sufficient degree have to be incorporated into these skin tanning agents.
- These so called light filtering agents are still regarded undesirable due to a possible disturbence of the biological equilibrium of the skin and the toxicity of these compounds for humans in large concentrations due to accumulation.
- novel sun tanning compositions of the invention are comprised of (a) 5 to 50% by weight of an oil fraction of straight or branched paraffinic oils of 10 to 30 carbon atoms with a boiling range of 100° to 500° C. at atmospheric pressure and a viscosity of at most 35 centistokes at 25° C.
- emulsifying system comprising (1) 1 to 10% by weight of mono and/or diglycerides of higher optionally unsaturated natural fatty acids and (2) ethoxylated glycerides esterified with fatty acids of the formula ##STR2## wherein n is an integer from 5 to 20 and the R's are individually an optionally unsaturated fatty acid residue derived from animal or vegetable oils with a ratio of 10 to 100 parts by weight of (1) per part of weight of (2), (c) .[.1.0 to 5% by weight of a mixture.].
- the oil fraction consists of straight or branched parrafinic oils containing 10 to 30 carbon atoms in the chain and preferably 12 to 25 carbon atoms in an amount of 5 to 50% by weight and preferably from 10 to 40% by weight, calculated on the weight of the total system.
- paraffinic oils have a boiling range of from 100° to 500° C. at atmospheric pressure and show a viscosity of at most 35 centistokes at 25° C.
- the paraffinic oils may be optionally mixed with esters of optionally unsaturated higher natural fatty acids and of higher natural aliphatic alcohols of up to 20 carbon atoms in the chain such as oleyl oleate or oleyl decalate (e.g. Cetiol V®.
- esters of optionally unsaturated higher natural fatty acids and of higher natural aliphatic alcohols of up to 20 carbon atoms in the chain such as oleyl oleate or oleyl decalate (e.g. Cetiol V®.
- the terms "higher natural fatty acids” and “higher natural alcohols” mean fatty acids and alcohols which maybe derived from products occurring in nature such as animal or vegetable oils and fats such as linseed oil, sunflower oil, rape oil, whale oil, castor oil, peanut oil, palm oil, olive oil, coconut oil, soybean oil, tung oil. It appears that for the most effective compositions, these esters are added to the paraffinic oil fractions in an
- the emulsifying system mainly consists of (a) mono and/or diglycerides of higher unsaturated and/or saturated natural fatty acids such as linoleic acid, oleic acid, linolenic acid, eleostearic acid, palmitic acid, lauric acid, or mixtures thereof (e.g.
- Tegomuls® in an amount of 1 to 10% by weight and preferably 2 to 8% by weight, calculated on the weight of the complete composition, and (b) ethoxylated glycerides derived from fatty acids of the formula ##STR3## wherein n is a number from 5 to 20 and preferably from 7 to 15 and R is a saturated or unsaturated and preferably unsaturated fatty acid residue derived from vegetable or animal oils, while R may be same or different fatty acid residues in one molecule, but preferably the same (e.g. Tagat TO®.
- the emulsifying system only will have to be used in relatively small amounts of the decidedly indispensable, but with reference to skin affections undesired emulsifier, whereas on the other hand the present emulsifying system may be regarded as especially affable to the skin, which feature is connected with a relatively low hydrophilic-lipophylic balance value.
- the ratio between the amount of the mono and diglycerides and the ethoxylated triglycerides may vary, whereas the advantageous characteristics are maintained, from 10 to 100 parts of mono and diglycerides per part of ethoxylated triglycerides and preferably 25 parts of mono and/or diglycerides per part of ethoxylated triglycerides.
- the total amount of the emulsifying system, calculated on the weight of the total composition may vary from 1 to 10% by weight and preferably 2 to 8% by weight, for the most optimal results.
- the stabilizer consists of montmorillonites whose free oxygen sites are occupied by quaternary groups (quaternary modified montmorillonites).
- quaternary modified montmorillonites examples of such stabilizers which are preferably employed are Bentone® or Propoloid® preparations which are added in an amount of from 0.2 to 4% by weight and preferably 0.5 to 2% by weight, calculated on the weight of the total composition.
- Panthenol may be used in one of its pure optical isomeric forms or as a racemic mixture, but preferably as D-panthenol, and tyrosine in one of its pure optical isomer forms or as racemic mixture, but preferably as L-tyrosine, or a compound from which the tyrosine easily may be formed in situ such as e.g. esters of tyrosine or phenylalanine which are known to be readily soluble in the aqueous phase. It will be appreciated that it is generally known that phenylalanine can be easily converted into tyrosine under natural conditions.
- Tyrosine is preferably added in the form of lower alkyl esters such as methyl, ethyl, (iso)propyl or (iso)butyl ester or in the form of the stearyl ester or the benzyl ester wherein the amino group optionally may be temporarily protected in a known way and is preferably protected by HCl addition.
- the aqueous phase wherein the panthenol and the tyrosine ester ultimately have to be present may have a pH in the range of 4 to 7 and more preferably in the range of 4 to 6 which may be obtained by addition of suitable alkaline agent such as sodium citrate and/or sodium hydroxide, especially in the case of protection of the amino group by HCl addition.
- suitable alkaline agent such as sodium citrate and/or sodium hydroxide
- the amounts of e.g. sodium citrate and/or sodium hydroxide will vary, depending on the specific protecting groups in the starting tyrosine derivative from 0.1 to 3% by weight, calculated on the weight of the complete composition.
- the molar ratio of tyrosine and panthenol should be in the range from 2:1 to 1:3 reach the indicated attractive properties of the compositions of the invention while the amounts of panthenol and tyrosine or tyrosine providing means should be 1 to 5% by weight (and preferably 2 to 4% by weight) and 0.5 to 5% by weight (preferably 1 to 4% by weight) respectively, calculated on the weight of the complete composition.
- the preservative is preferably selected from different types of preservatives which can be used for the ultimately formed continuous oily phase and the dispersed aqueous phase.
- esters of p-hydroxy benzoic acid are used for the oily phase and preferably the methyl and/or the (iso)propyl ester and/or (iso)butyl ester is used in an amount of 0.05 to 1% by weight, calculated on the weight of the complete composition, and preferably in an amount of 0.2 to 0.4% by weight.
- Preferred are mixtures of methyl, propyl and butyl-p-hydroxy-benzoate (e.g. Phenonip®.
- preservatives may be completely or partially replaced by other preservatives (e.g. Germall 115® or Hydroconserv® in an amount of 0.05 to 1% by weight and preferably 0.2 to 0.4% by weight in the dispersed aqueous phase.
- other preservatives e.g. Germall 115® or Hydroconserv® in an amount of 0.05 to 1% by weight and preferably 0.2 to 0.4% by weight in the dispersed aqueous phase.
- one or more secondary ingredients also can be added to the final composition if desired, such as: (a) vitamin E as such or preferably in the relatively stable acetate form in an amount of 0.05 to 5% by weight calculated on the weight of the complete composition and preferably in an amount of from 0.2 to 2% by weight. (b) glycerol in an amount of 0.5 to 5.0% by weight, calculated on the weight of the complete composition and preferably in an amount of from 1 to 3% by weight, to form a moisture regulating system, together with the panthenol and optionally co-added sodium lactate and/or possibly alkali to maintain the desired pH of from 4 to 7 such as sodium citrate.
- vitamin E as such or preferably in the relatively stable acetate form in an amount of 0.05 to 5% by weight calculated on the weight of the complete composition and preferably in an amount of from 0.2 to 2% by weight.
- glycerol in an amount of 0.5 to 5.0% by weight, calculated on the weight of the complete composition and preferably in an amount of from 1
- alkali such as sodium citrate, sodium hydroxide and optional sodium lactate will vary from 0.1 to 5% by weight.
- a gelforming agents such as carraghenate, preferably consisting of a polysaccharide bearing sulfonic acid residues, and preferably those of natural origin such as those derived from seaweed. The sulfonic acid residues have optionally been converted into salts or esters of glycol, propylene glycol and glycerol (the so called modified carraghenates).
- the beforementioned carraghenates cause a gel structure in the final complete composition in the amounts of from 0.1 to 5% by weight, calculated on the weight of the complete composition, and preferably 0.5 to 2% by weight.
- a complete composition shows a viscosity of 200 to 5000 centipoises at 25° C., which is desired for an adequate application of the composition.
- the carraghenate may be completely or partially replaced by alternative gel forming means, such as carboxy methyl cellulose, esterified by polyacrylic acid (e.g. Carbopol® or hydroxy ethyl cellulose, in amounts which lead to viscosity values situated in the beforementioned range.
- perfume in an amount of from 0.1 to 0.5% by weight, calculated on the weight of the complete composition .
- anti oxidants in an amount of from 0.01 to 3% by weight, calculated on the weight of the complete composition.
- an alkanol and more preferably ethanol (96%) in an amount of from 0.1 to 1.0% by weight and preferably 0.3 to 0.6% by weight, calculated on the weight of the complete composition.
- the alkanol may be added to reach a fat gelation of the quaternary modified montmorillonites.
- compositions of the invention are characterized by a relatively low viscosity and high stability which guarantees an easy application without a "greasy” feeling or stickiness and stains in clothes due to a fast penetration into the skin tissue, and they give the skin the desired tanning by means of natural pigment formation in the skin after a relatively short period of exposure to light.
- compositions of the invention may be prepared by a process which should be regarded as another aspect of the invention which is characterized by a specific sequence of addition and the dosing rate of the respective beforementioned ingredients and by the temperature and stirring speeds at which this addition c.q. dosing takes place.
- the first step of the process comprises the preparation of the complete continuous oily phase composed of the oil fractions, the esters of the unsaturated fatty acids and alcohols, emulsifying system, stabilizers, preservatives and alkanol, e.g. ethanol while the dispersed aqueous phase is composed of water, glycerol, panthenol, tyrosine or tyrosine providing compound, desired alkali and carraghenate. Vitamin E and the possible perfume may be added to the prepared emulsion.
- compositions of the invention are preferably preferred by mixing both phases together at a temperature of at most 30° C., followed by additional stirring after the possible addition of Vitamin E and perfume until an average particle size of the dispersed aqueous phase is at most 5 ⁇ , and preferably smaller than 3 ⁇ .
- compositions i.e. the treatment of the skin with the before described compositions
- Such an application comprises a method usual for such compositions characterized by application and spreading evenly onto the skin area involved of an amount of 20 to 100 ml/m 2 skin area, if necessary after thorough cleaning of the skin with water and soap or an alcoholic solution, preceeding the exposure of the skin to natural or artificial sunlight.
- This treatment should be preferably be repeated 2 to 3 times a day.
- the aqueous phase was prepared by dissolving the following ingredients in 687 g of water
- the resulting aqueous phase was then mixed with the oily phase and homogenized after addition of 10 g of vitamin E-acetate (D-isomer) and 2 g of perfume.
- the water-in-oil emulsion was further homogenized until an average particle size ⁇ 3 ⁇ was reached.
- Example 2 Using the procedure of Example 1, a composition was prepared from the following ingredients:
- Example 2 Using the procedure of Example 1, a composition was prepared from the following ingredients:
- composition was prepared from the following ingredients:
- Example 2 Using the procedure of Example 1, a composition was prepared from the following ingredients:
- compositions caused a fast, intensive natural skin tanning within some hours of exposure after the application in the usual way.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
Abstract
A skin tanning composition comprising (a) 5 to 50% by weight of an oil fraction of straight or branched paraffinic oils of 10 to 30 carbon atoms with a boiling range of 100° to 500° C. at atmospheric pressure and a viscosity of at most 35 centistokes at 25° C., optionally containing up to 6% by weight of esters of optionally unsaturated higher natural fatty acids and optionally unsaturated natural aliphatic alcohols of up to 20 carbon atoms, (b) 1 to 10% by weight of an emulsifying system comprising (1) 1 to 10% by weight of mono and/or diglycerides of higher optionally unsaturated natural fatty acids and (2) ethoxylated glycerides esterified with fatty acids of the formula ##STR1## wherein n is an integer from 5 to 20 and the R's are individually an optionally unsaturated fatty acid residue derived from animal or vegetable oils with a ratio of 10 to 100 parts by weight of (1) per part by weight of (2), (c) .Iadd.(.Iaddend.1.0 to 5% by weight of a mixture.Iadd.) .Iaddend..Iadd.1 to 5% by weight of panthenol and 0.5 to 5% by weight of tyrosine or tyrosine precursor in a molar ratio .Iaddend.of 2:1 to 1:3 of tyrosine or tyrosine precursor to panthenol, (d) sufficient alkali to maintain the pH of the aqueous phase at 4 to 7, (e) 0.2 to 4% by weight of a montmorillonite stablizer with free oxygen sites occupied by quaternary groups, (f) 0.5 to 1.0% by weight of a preservative for the formed continuous phase and (g) water to make up 100% by weight, the weights being based on the weight of the entire composition to effect relatively fast skin tanning upon exposure to natural sun light or from artificial sun tanning equipment such as sunbeds and solaria while avoiding exposure to compounds which can disturb the biological equilibrium of the skin.
Description
This application is a continuation of U.S. patent application Ser. No. 344,203 filed Apr. 27, 1989, now abandoned which is a reissue of Ser. No. 064,331, filed Jun. 19, 1987, now U.S. Pat. No. 4,783,332.
Many compositions have been proposed for skin tanning over the course of the years. Some of these proposed compositions contain as active main ingredient panthenol which is applied in an acid, non aqueous phase, and are indeed effecting the desired skin tanning after exposure to natural or artificial sunlight. However, in the opinion of the modern consumer, the action is too slow. For this reason, compounds which have to protect the skin temporarily against excessive interaction of harmful frequencies in the light spectrum, leading to burning before the actual skin tanning process due to the natural production of melanoprotein (pigment) has taken place in a sufficient degree, have to be incorporated into these skin tanning agents. These so called light filtering agents are still regarded undesirable due to a possible disturbence of the biological equilibrium of the skin and the toxicity of these compounds for humans in large concentrations due to accumulation.
It is an object of the invention to provide novel tanning compositions containing harmless, fast acting skin tanning agents, wherein the light filtering agents do not need to be used.
It is another object of the invention to provide an improved method of fast tanning of skin.
These and other objects and advantages of the invention will become obvious from the following detailed description.
The novel sun tanning compositions of the invention are comprised of (a) 5 to 50% by weight of an oil fraction of straight or branched paraffinic oils of 10 to 30 carbon atoms with a boiling range of 100° to 500° C. at atmospheric pressure and a viscosity of at most 35 centistokes at 25° C. optionally containing up to 6% by weight of esters of optionally unsaturated higher natural fatty acids and optionally unsaturated natural aliphatic alcohols of up to 20 carbon atoms, (b) 1 to 10% by weight of an emulsifying system comprising (1) 1 to 10% by weight of mono and/or diglycerides of higher optionally unsaturated natural fatty acids and (2) ethoxylated glycerides esterified with fatty acids of the formula ##STR2## wherein n is an integer from 5 to 20 and the R's are individually an optionally unsaturated fatty acid residue derived from animal or vegetable oils with a ratio of 10 to 100 parts by weight of (1) per part of weight of (2), (c) .[.1.0 to 5% by weight of a mixture.]. .Iadd.1 to 5% by weight of panthenol and 0.5 to 5% by weight of tyrosine or tyrosine precursor in a molar ratio .Iaddend.of 2:1 to 1:3 of tyrosine or tyrosine precursor to panthenol, (d) sufficient alkali to maintain the pH of the aqueous phase at 4 to 7, (e) 0.2 to 4% by weight of a montmorillonite stabilizer with free oxygen sites occupied by quaternary groups, (f) 0.05 to 1.0% by weight of a preservative for the formed continuous oily phase and the dispersed aqueous phase and (g) water to make up 100% by weight, the weights being based on the weight of the entire composition.
Preferably, the oil fraction consists of straight or branched parrafinic oils containing 10 to 30 carbon atoms in the chain and preferably 12 to 25 carbon atoms in an amount of 5 to 50% by weight and preferably from 10 to 40% by weight, calculated on the weight of the total system. These paraffinic oils have a boiling range of from 100° to 500° C. at atmospheric pressure and show a viscosity of at most 35 centistokes at 25° C.
The paraffinic oils may be optionally mixed with esters of optionally unsaturated higher natural fatty acids and of higher natural aliphatic alcohols of up to 20 carbon atoms in the chain such as oleyl oleate or oleyl decalate (e.g. Cetiol V®. The terms "higher natural fatty acids" and "higher natural alcohols" mean fatty acids and alcohols which maybe derived from products occurring in nature such as animal or vegetable oils and fats such as linseed oil, sunflower oil, rape oil, whale oil, castor oil, peanut oil, palm oil, olive oil, coconut oil, soybean oil, tung oil. It appears that for the most effective compositions, these esters are added to the paraffinic oil fractions in an amount up to 6% by weight and preferably 2 to 5% by weight, based on the weight of the total composition.
The emulsifying system mainly consists of (a) mono and/or diglycerides of higher unsaturated and/or saturated natural fatty acids such as linoleic acid, oleic acid, linolenic acid, eleostearic acid, palmitic acid, lauric acid, or mixtures thereof (e.g. Tegomuls® in an amount of 1 to 10% by weight and preferably 2 to 8% by weight, calculated on the weight of the complete composition, and (b) ethoxylated glycerides derived from fatty acids of the formula ##STR3## wherein n is a number from 5 to 20 and preferably from 7 to 15 and R is a saturated or unsaturated and preferably unsaturated fatty acid residue derived from vegetable or animal oils, while R may be same or different fatty acid residues in one molecule, but preferably the same (e.g. Tagat TO®.
It will be appreciated that the emulsifying system only will have to be used in relatively small amounts of the decidedly indispensable, but with reference to skin affections undesired emulsifier, whereas on the other hand the present emulsifying system may be regarded as especially affable to the skin, which feature is connected with a relatively low hydrophilic-lipophylic balance value. The ratio between the amount of the mono and diglycerides and the ethoxylated triglycerides may vary, whereas the advantageous characteristics are maintained, from 10 to 100 parts of mono and diglycerides per part of ethoxylated triglycerides and preferably 25 parts of mono and/or diglycerides per part of ethoxylated triglycerides. The total amount of the emulsifying system, calculated on the weight of the total composition, may vary from 1 to 10% by weight and preferably 2 to 8% by weight, for the most optimal results.
The stabilizer consists of montmorillonites whose free oxygen sites are occupied by quaternary groups (quaternary modified montmorillonites). Examples of such stabilizers which are preferably employed are Bentone® or Propoloid® preparations which are added in an amount of from 0.2 to 4% by weight and preferably 0.5 to 2% by weight, calculated on the weight of the total composition. By addition of the said stabilizers, deposit of one or more of the ingredients of the compositions is avoided in the relatively low viscous compositions which are preferred for practical reasons.
Panthenol (provitamin B-5) may be used in one of its pure optical isomeric forms or as a racemic mixture, but preferably as D-panthenol, and tyrosine in one of its pure optical isomer forms or as racemic mixture, but preferably as L-tyrosine, or a compound from which the tyrosine easily may be formed in situ such as e.g. esters of tyrosine or phenylalanine which are known to be readily soluble in the aqueous phase. It will be appreciated that it is generally known that phenylalanine can be easily converted into tyrosine under natural conditions.
With regard to the known poor solubility of tyrosine as such in an aqueous phase, the good properties of the present compositions could certainly not be expected or predicted by people skilled in the art. Tyrosine is preferably added in the form of lower alkyl esters such as methyl, ethyl, (iso)propyl or (iso)butyl ester or in the form of the stearyl ester or the benzyl ester wherein the amino group optionally may be temporarily protected in a known way and is preferably protected by HCl addition.
Additionally, it was found that the aqueous phase wherein the panthenol and the tyrosine ester ultimately have to be present may have a pH in the range of 4 to 7 and more preferably in the range of 4 to 6 which may be obtained by addition of suitable alkaline agent such as sodium citrate and/or sodium hydroxide, especially in the case of protection of the amino group by HCl addition. The amounts of e.g. sodium citrate and/or sodium hydroxide will vary, depending on the specific protecting groups in the starting tyrosine derivative from 0.1 to 3% by weight, calculated on the weight of the complete composition.
The molar ratio of tyrosine and panthenol should be in the range from 2:1 to 1:3 reach the indicated attractive properties of the compositions of the invention while the amounts of panthenol and tyrosine or tyrosine providing means should be 1 to 5% by weight (and preferably 2 to 4% by weight) and 0.5 to 5% by weight (preferably 1 to 4% by weight) respectively, calculated on the weight of the complete composition.
The preservative is preferably selected from different types of preservatives which can be used for the ultimately formed continuous oily phase and the dispersed aqueous phase. For example, esters of p-hydroxy benzoic acid are used for the oily phase and preferably the methyl and/or the (iso)propyl ester and/or (iso)butyl ester is used in an amount of 0.05 to 1% by weight, calculated on the weight of the complete composition, and preferably in an amount of 0.2 to 0.4% by weight. Preferred are mixtures of methyl, propyl and butyl-p-hydroxy-benzoate (e.g. Phenonip®. It will be appreciated that the said preservatives may be completely or partially replaced by other preservatives (e.g. Germall 115® or Hydroconserv® in an amount of 0.05 to 1% by weight and preferably 0.2 to 0.4% by weight in the dispersed aqueous phase.
In addition to the beforementioned primary indispensable ingredients, one or more secondary ingredients also can be added to the final composition if desired, such as: (a) vitamin E as such or preferably in the relatively stable acetate form in an amount of 0.05 to 5% by weight calculated on the weight of the complete composition and preferably in an amount of from 0.2 to 2% by weight. (b) glycerol in an amount of 0.5 to 5.0% by weight, calculated on the weight of the complete composition and preferably in an amount of from 1 to 3% by weight, to form a moisture regulating system, together with the panthenol and optionally co-added sodium lactate and/or possibly alkali to maintain the desired pH of from 4 to 7 such as sodium citrate. The total amount of alkali such as sodium citrate, sodium hydroxide and optional sodium lactate will vary from 0.1 to 5% by weight. (c) a gelforming agents such as carraghenate, preferably consisting of a polysaccharide bearing sulfonic acid residues, and preferably those of natural origin such as those derived from seaweed. The sulfonic acid residues have optionally been converted into salts or esters of glycol, propylene glycol and glycerol (the so called modified carraghenates).
The beforementioned carraghenates cause a gel structure in the final complete composition in the amounts of from 0.1 to 5% by weight, calculated on the weight of the complete composition, and preferably 0.5 to 2% by weight. Such a complete composition shows a viscosity of 200 to 5000 centipoises at 25° C., which is desired for an adequate application of the composition. It will be appreciated by a person skilled in this specific art, that the carraghenate may be completely or partially replaced by alternative gel forming means, such as carboxy methyl cellulose, esterified by polyacrylic acid (e.g. Carbopol® or hydroxy ethyl cellulose, in amounts which lead to viscosity values situated in the beforementioned range.
Also useful are (d) perfume, in an amount of from 0.1 to 0.5% by weight, calculated on the weight of the complete composition . (e) anti oxidants in an amount of from 0.01 to 3% by weight, calculated on the weight of the complete composition. (f) an alkanol, and more preferably ethanol (96%) in an amount of from 0.1 to 1.0% by weight and preferably 0.3 to 0.6% by weight, calculated on the weight of the complete composition. The alkanol may be added to reach a fat gelation of the quaternary modified montmorillonites.
The compositions of the invention are characterized by a relatively low viscosity and high stability which guarantees an easy application without a "greasy" feeling or stickiness and stains in clothes due to a fast penetration into the skin tissue, and they give the skin the desired tanning by means of natural pigment formation in the skin after a relatively short period of exposure to light.
The compositions of the invention may be prepared by a process which should be regarded as another aspect of the invention which is characterized by a specific sequence of addition and the dosing rate of the respective beforementioned ingredients and by the temperature and stirring speeds at which this addition c.q. dosing takes place.
The first step of the process comprises the preparation of the complete continuous oily phase composed of the oil fractions, the esters of the unsaturated fatty acids and alcohols, emulsifying system, stabilizers, preservatives and alkanol, e.g. ethanol while the dispersed aqueous phase is composed of water, glycerol, panthenol, tyrosine or tyrosine providing compound, desired alkali and carraghenate. Vitamin E and the possible perfume may be added to the prepared emulsion.
The compositions of the invention are preferably preferred by mixing both phases together at a temperature of at most 30° C., followed by additional stirring after the possible addition of Vitamin E and perfume until an average particle size of the dispersed aqueous phase is at most 5μ, and preferably smaller than 3μ.
It will be appreciated by a person skilled in the art that the application of the said compositions, i.e. the treatment of the skin with the before described compositions, forms another aspect of the invention. Such an application comprises a method usual for such compositions characterized by application and spreading evenly onto the skin area involved of an amount of 20 to 100 ml/m2 skin area, if necessary after thorough cleaning of the skin with water and soap or an alcoholic solution, preceeding the exposure of the skin to natural or artificial sunlight. This treatment should be preferably be repeated 2 to 3 times a day.
In the following examples there are described several preferred embodiments to illustrate the invention. However, it should be understood that the invention is not intended to be limited to the specific embodiments.
______________________________________
Paraffinic oil I 130 g
(Shell Ondina 15 ®, boiling range 295 to
390° C.)
Paraffinic oil II 30 g
(Shell Ondina 68 ®, boiling range 290 to
500° C.)
Mono and/or diglycerides (Tegomuls ®)
25 g oily
Oleyl decalate (Cetiol V ®)
30 g phase
Ethoxylated triglycerides (Tagat TO ®)
1 g
Preservatives I (Phenonip ®)
2 g
followed by addition of quaternary modified
6 g
montmorillonites (Bentone 38 ®)
and gelation by addition of 96% ethanol
3 g
______________________________________
The aqueous phase was prepared by dissolving the following ingredients in 687 g of water
______________________________________
Glycerol 20 g
Phenyl alanine 20 g
Sodium citrate 10 g aqueous
D-panthenol 16 g phase
Preservative II (Hydroconserv ®)
3 g
Carraghenate 5 g
______________________________________
The resulting aqueous phase was then mixed with the oily phase and homogenized after addition of 10 g of vitamin E-acetate (D-isomer) and 2 g of perfume. The water-in-oil emulsion was further homogenized until an average particle size <3 μwas reached.
Using the procedure of Example 1, a composition was prepared from the following ingredients:
______________________________________
Paraffinic oil I 250 g
Paraffinic oil II 50 g
Mono and/or diglycerides
40 g
Ethoxylated triglycerides
2 g oily
Preservative I 2 g phase
Quaternary modified montmorillonites
6 g
(Bentone 27 ®)
Ethanol 3 g
and
Water 580 g
Glycerol 15 g
L-tyrosine ethylate HCl
10 g
Sodium Hydroxide 1 g aqueous
D-panthenol 10 g phase
Sodium lactate 10 g
Preservative I 3 g
Carraghenate 8 g
and
Vitamin E-acetate (D-isomer)
8 g
Perfume 2 g
______________________________________
Using the procedure of Example 1, a composition was prepared from the following ingredients:
______________________________________
Paraffinic oil I 150 g
Paraffinic oil II 40 g
Mono and/or diglycerides
30 g
Ethoxylated triglycerides
1 g
Oleyl oleate 20 g oily phase
Preservative I 2 g
Quaternary modified
montmorillonites (Bentone 38 ®)
6 g
Ethanol 2 g
and
Water 659 g
Glycerol 15 g
L-tyrosine isobutylate
30 g aqueous -Sodium citrate 10 g phase
D-panthenol 20 g
Preservative III (Euxyl 100 ®)
3 g
and
Vitamin E-acetate (D-isomer)
10 g
Perfume 2 g
______________________________________
Using the procedure of Example 1, composition was prepared from the following ingredients:
______________________________________
Paraffinic oil I 140 g
Paraffinic oil II 25 g
Mono and/or diglycerides
15 g
Oleyl decalate 26 g
Ethoxylated triglycerides
0.5 g oily phase
Preservative I 3 g
Quaternary modified 7 g
montmorillonites (Bentone 27 ®)
Ethanol 3 g
and
Water 692.5 g
Glycerol 20 g
L-tyrosine ethylate HCl
15 g
Sodium hydroxide 10 g
D-panthenol 15 g aqueous
Sodium lactate 4 g phase
Sodium citrate 3 g
Preservative I 3 g
Carraghenate 8 g
and
Vitamin E-acetate (D-isomer)
7 g
Perfume 3 g
______________________________________
Using the procedure of Example 1, a composition was prepared from the following ingredients:
______________________________________
Paraffinic oil I 200 g
Paraffinic oil II 50 g
Mono and/or diglycerides
40 g
Ethoxylated triglycerides
2 g oily
Preservative I 2 g phase
Quaternary modified 6 g
montmorillonites (Benton 2 ®)
Isopropanol 2 g
and
Water 613 g
Glycerol 15 g
D,L-tyrosine isobutylate
25 g aqueous
D,L-Panthenol 20 g phase
Sodium citrate 10 g
Preservative III 3 g
Vitamin E-acetate (D,L)
10 g
Perfume 2 g
______________________________________
The said compositions caused a fast, intensive natural skin tanning within some hours of exposure after the application in the usual way.
Various modifications of the compositions and methods of the invention may be made without departing from the spirit or scope thereof and it is to be understood that the invention is intended to be limited only as defined in the appended claims.
Claims (10)
1. A skin tanning composition comprising (a) 5 to 50% by weight of an oil fraction of straight or branched paraffinic oils of 10 to 30 carbon atoms with a boiling range of 100° to 500° C. at atmospheric pressure and a viscosity of at most 35 centistokes at 25° C., containing 0 to 6% by weight of esters of saturated or unsaturated higher natural fatty acids and saturated or unsaturated natural aliphatic alcohols of up to 20 carbon atoms, (b) 1 to 10% by weight of of an emulsifying system comprising (1) to 10% by weight mono and/or diglycerides of higher saturated or unsaturated natural fatty acids and (2) ethoxylated glycerides esterified with fatty acids of the formula ##STR4## wherein n is an integer from 5 to 20 and the R's are individually a saturated or unsaturated fatty acid residue derived from animal or vegetable oils with a ratio of 10 to 100 parts by weight of (1) per part by weight of (2), (c) .[.1.0 to 5% by weight of a mixture.]..Iadd.1 to 5% by weight of panthenol and 0.5 to 5% by weight of tyrosine or tyrosine precursor in a molar ratio .Iaddend.of 2:1 to 1:3 of tyrosine or tyrosine precursor to panthenol, (d) sufficient alkali to maintain the pH of the aqueous phase at 4 to 7, (e) 0.2 4% by weight of a montmorillonite stabilizer with free oxygen sites occupied by quaternary groups, (f) 0.05 to 1.0% by weight of a preservative for the formed continuous oily phase and the dispersed aqueous phase and (g) water to make up 100% by weight, the weights being based on the weight of the entire composition.
2. A composition of claim 1 wherein (a) the paraffinic oils have 15 to 25 carbon atoms and the oil fraction is 10 to 40% by weight of the composition, (b) η is an integer from 7 to 15, (c) the panthenol is D-panthenol .Iadd.in an amount of 2 to 4% by weight and the tyrosine is L-tyrosine and the amount .[.of each of those components is 0.5 to 5%.]. .Iadd.is 1 to 4%by weight, .Iaddend.(d) the pH is 4 to 6 and the alkaline agent is sodium citrate and/or sodium hydroxide.
3. A composition of claim 1 wherein it further contains at least one ingredient selected from the group consisting of vitamin E is an amount of 0.05 to 5% by weight, glycerol in an amount of 0.5 to 5.0% by weight, alkanol in an amount of 0.1 to 1.0% by weight, sodium lactate in an amount of 0.1 to 5% by weight, gel forming agent in an amount of 0.1 to 5% by weight, perfume in an amount of 0.1 to 0.5% by weight and antioxidants in an amount of 0.01 to 3% by weight, calculated on the weight of the complete composition.
4. A composition of claim 1 wherein it contains an oil fraction in an amount of 10 to 40% by weight.
5. A composition of claim 1 wherein the oil fraction is mixed with oleyl oleate or oleyl decalate in an amount of 2 to 5% by weight, calculated on the weight of the complete composition.
6. A composition of claim 1 wherein the emulsifying system is composed of ethoxylated triglycerides derived from linoleic acid, oleic acid, linolenic acid or mixtures thereof mixed with mono and/or diglycerides derived from linoleic acid, linolenic acid, oleic acid, palmitic acid, lauric acid, myristic acid, stearic acid, eleostearic acid and mixtures thereof.
7. A composition of claim 1 wherein the ratio between mono and/or diglycerides and ethoxylated triglycerides is 25 parts mono and/or diglycerides per part of ethoxylated triglycerides.
8. A composition of claim 1 wherein the preservative in the oily phase is at least one ester of p-hydroxybenzoic acid in an amount of 0.2 to 4% by weight.
9. A process for the preparation of a composition of claim 1 comprising preparing an oily phase by addition of the emulsifying system, preservative and stabilizer to the oily components with stirring and heating until gelation after addition of alcohol followed by cooling to at most 30° C. and addition of the aqueous phase composed of water, preservative, glycerol, panthenol, tyrosine or tyrosine providing compound sufficient alkali and carraghenate.
10. In a method of tanning skin, the improvement comprising applying 20 to 100 ml/m2 skin area of a composition of claim 1 to the skin area involved and then subjecting the skin to the exposure of natural or artificial sunlight.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8601767A NL8601767A (en) | 1986-07-07 | 1986-07-07 | SKIN TANNING AGENT. |
| NL8601767 | 1986-07-07 |
Related Parent Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/064,331 Reissue US4783332A (en) | 1986-07-07 | 1987-06-19 | Novel skin tanning composition |
| US07344203 Continuation | 1989-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USRE33845E true USRE33845E (en) | 1992-03-10 |
Family
ID=19848277
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/064,331 Ceased US4783332A (en) | 1986-07-07 | 1987-06-19 | Novel skin tanning composition |
| US07/630,822 Expired - Lifetime USRE33845E (en) | 1986-07-07 | 1990-12-20 | Novel skin tanning composition |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/064,331 Ceased US4783332A (en) | 1986-07-07 | 1987-06-19 | Novel skin tanning composition |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US4783332A (en) |
| EP (1) | EP0255964B1 (en) |
| JP (1) | JPS6322515A (en) |
| AT (1) | ATE62399T1 (en) |
| AU (1) | AU594165B2 (en) |
| CA (1) | CA1294555C (en) |
| DE (1) | DE3769240D1 (en) |
| DK (1) | DK342387A (en) |
| ES (1) | ES2021343B3 (en) |
| FI (1) | FI872962A7 (en) |
| GR (1) | GR3001766T3 (en) |
| NL (1) | NL8601767A (en) |
| NO (1) | NO872749L (en) |
| NZ (1) | NZ220818A (en) |
| PT (1) | PT85259B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5484816A (en) * | 1992-07-13 | 1996-01-16 | Shiseido Company, Ltd. | External skin treatment composition |
| US6017517A (en) | 1996-12-18 | 2000-01-25 | The Dial Corporation | Method for treating human nails |
| US6036946A (en) | 1997-12-24 | 2000-03-14 | Shaklee Corporation | Methods for protecting skin from damaging effects of ultraviolet light |
| US6146664A (en) | 1998-07-10 | 2000-11-14 | Shaklee Corporation | Stable topical ascorbic acid compositions |
| US7467420B2 (en) | 2005-07-26 | 2008-12-23 | Laura Ponce | Applicator glove for application of staining compositions and self-tanning kit including same |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0203211A1 (en) * | 1985-05-28 | 1986-12-03 | Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. | Composition for treatment of skin affections and process for its preparation |
| US5290562A (en) * | 1987-11-27 | 1994-03-01 | L V M H Recherche | Compositions and methods employing liposomes including tyrosine or a tyrosine derivative |
| AU2971689A (en) * | 1988-02-11 | 1989-08-17 | Estee Lauder Inc. | Tanning compositions and their use |
| US5700450A (en) * | 1988-03-30 | 1997-12-23 | The Trustees Of Boston University | Methods for enhancing melanin synthesis in melanocytes using diacyglycerols and uses thereof |
| US5352440A (en) * | 1988-03-30 | 1994-10-04 | Trustees Of Boston University | Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof |
| ATE112484T1 (en) * | 1989-01-11 | 1994-10-15 | Schreuder Chem Adviesbureau | AQUEOUS SKIN TANNING AGENT. |
| US20020197309A1 (en) * | 1989-09-05 | 2002-12-26 | Kuczynski Anthony L. | Method for lowering blood glucose |
| CA2053147A1 (en) * | 1990-10-15 | 1992-04-16 | Charles F. Cooper | Esterified polyoxyalkylene block copolymers as reduced calorie fat substitutes |
| US5643554A (en) * | 1993-04-30 | 1997-07-01 | Dusa Pharmaceuticals, Inc. | Lipomelanim composition |
| JPH07238010A (en) * | 1994-02-24 | 1995-09-12 | Kanebo Ltd | Skin cosmetic |
| US20030017181A1 (en) | 2001-05-31 | 2003-01-23 | Rood Gloria A. | Dermatological compositions and methods |
| US6960563B2 (en) * | 2001-08-31 | 2005-11-01 | Morton Grove Pharmaceuticals, Inc. | Spontaneous emulsions containing cyclosporine |
| DE10211752A1 (en) * | 2002-03-18 | 2003-10-02 | Richter Chem Lab | P / O emulsions containing amino functional polyols |
| EP1863437B1 (en) * | 2005-03-24 | 2014-02-26 | Beiersdorf Ag | Use of preparations for skin enzyme protection |
| WO2007019048A2 (en) * | 2005-08-02 | 2007-02-15 | Mary Kay Inc. | High ph compositions |
| US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3037015A (en) * | 1958-07-19 | 1962-05-29 | Benckiser Gmbh Joh A | Therapeutically valuable compounds and process of producing same |
| US3230228A (en) * | 1961-03-30 | 1966-01-18 | Hoffmann La Roche | Panthenol derivatives and processes for their preparation |
| DE2122291A1 (en) * | 1970-05-06 | 1971-11-18 | Saint-Gobain, Neuilly-sur-Seine; Etablissements Gattefosse, Saint-Priest; (Frankreich) | Sunscreen preparations and processes for their manufacture |
| FR2326914A1 (en) * | 1975-10-11 | 1977-05-06 | Lion Dentifrice Co Ltd | WATER / OIL / WATER COMPLEX EMULSION, PROCESS FOR ITS PREPARATION AND APPLICATION TO COSMETIC PRODUCTS |
| US4349536A (en) * | 1980-03-11 | 1982-09-14 | Hausler Kenneth J | Method of promoting suntan using a cream containing zinc and copper salts |
| US4690774A (en) * | 1985-09-11 | 1987-09-01 | Chesebrough Pond's Inc. | Novel translucent water in oil emulsions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2722725A1 (en) * | 1977-05-20 | 1978-11-30 | Merck Patent Gmbh | COSMETIC MEANS |
| CA1138292A (en) * | 1978-06-30 | 1982-12-28 | Johannes C.P. Schreuder | Handwashing composition |
| CH642537A5 (en) * | 1980-01-25 | 1984-04-30 | Uni Chemie Ag | Cosmetic sunscreen product |
-
1986
- 1986-07-07 NL NL8601767A patent/NL8601767A/en not_active Application Discontinuation
-
1987
- 1987-06-12 EP EP87201116A patent/EP0255964B1/en not_active Expired - Lifetime
- 1987-06-12 AT AT87201116T patent/ATE62399T1/en not_active IP Right Cessation
- 1987-06-12 CA CA000539519A patent/CA1294555C/en not_active Expired - Lifetime
- 1987-06-12 ES ES87201116T patent/ES2021343B3/en not_active Expired - Lifetime
- 1987-06-12 DE DE8787201116T patent/DE3769240D1/en not_active Expired - Fee Related
- 1987-06-19 US US07/064,331 patent/US4783332A/en not_active Ceased
- 1987-06-23 AU AU74609/87A patent/AU594165B2/en not_active Ceased
- 1987-06-24 NZ NZ220818A patent/NZ220818A/en unknown
- 1987-07-01 NO NO872749A patent/NO872749L/en unknown
- 1987-07-03 FI FI872962A patent/FI872962A7/en not_active Application Discontinuation
- 1987-07-03 DK DK342387A patent/DK342387A/en not_active Application Discontinuation
- 1987-07-03 JP JP62166762A patent/JPS6322515A/en active Pending
- 1987-07-06 PT PT85259A patent/PT85259B/en not_active IP Right Cessation
-
1990
- 1990-12-20 US US07/630,822 patent/USRE33845E/en not_active Expired - Lifetime
-
1991
- 1991-04-11 GR GR91400456T patent/GR3001766T3/en unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3037015A (en) * | 1958-07-19 | 1962-05-29 | Benckiser Gmbh Joh A | Therapeutically valuable compounds and process of producing same |
| US3230228A (en) * | 1961-03-30 | 1966-01-18 | Hoffmann La Roche | Panthenol derivatives and processes for their preparation |
| DE2122291A1 (en) * | 1970-05-06 | 1971-11-18 | Saint-Gobain, Neuilly-sur-Seine; Etablissements Gattefosse, Saint-Priest; (Frankreich) | Sunscreen preparations and processes for their manufacture |
| FR2326914A1 (en) * | 1975-10-11 | 1977-05-06 | Lion Dentifrice Co Ltd | WATER / OIL / WATER COMPLEX EMULSION, PROCESS FOR ITS PREPARATION AND APPLICATION TO COSMETIC PRODUCTS |
| US4349536A (en) * | 1980-03-11 | 1982-09-14 | Hausler Kenneth J | Method of promoting suntan using a cream containing zinc and copper salts |
| US4690774A (en) * | 1985-09-11 | 1987-09-01 | Chesebrough Pond's Inc. | Novel translucent water in oil emulsions |
Non-Patent Citations (2)
| Title |
|---|
| Sagarin Cosmetics Science and Technology, 1957, pp. 192 196, 1113 1117. * |
| Sagarin Cosmetics Science and Technology, 1957, pp. 192-196, 1113-1117. |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5484816A (en) * | 1992-07-13 | 1996-01-16 | Shiseido Company, Ltd. | External skin treatment composition |
| US6024941A (en) | 1992-07-13 | 2000-02-15 | Shiseido Company, Ltd. | External skin treatment composition |
| US6017517A (en) | 1996-12-18 | 2000-01-25 | The Dial Corporation | Method for treating human nails |
| US6036946A (en) | 1997-12-24 | 2000-03-14 | Shaklee Corporation | Methods for protecting skin from damaging effects of ultraviolet light |
| US6174519B1 (en) | 1997-12-24 | 2001-01-16 | Shaklee Corporation | Composition for protecting skin from damaging effects of ultraviolet light |
| US6146664A (en) | 1998-07-10 | 2000-11-14 | Shaklee Corporation | Stable topical ascorbic acid compositions |
| US7467420B2 (en) | 2005-07-26 | 2008-12-23 | Laura Ponce | Applicator glove for application of staining compositions and self-tanning kit including same |
| US20090100574A1 (en) * | 2005-07-26 | 2009-04-23 | Laura Ponce | Applicator Glove For Application Of Staining Compositions And Self-Tanning Kit Including Same |
Also Published As
| Publication number | Publication date |
|---|---|
| DK342387A (en) | 1988-01-08 |
| DK342387D0 (en) | 1987-07-03 |
| US4783332A (en) | 1988-11-08 |
| JPS6322515A (en) | 1988-01-30 |
| EP0255964A1 (en) | 1988-02-17 |
| GR3001766T3 (en) | 1992-11-23 |
| AU7460987A (en) | 1988-01-14 |
| NZ220818A (en) | 1989-10-27 |
| DE3769240D1 (en) | 1991-05-16 |
| ATE62399T1 (en) | 1991-04-15 |
| NO872749L (en) | 1988-01-08 |
| NO872749D0 (en) | 1987-07-01 |
| FI872962A7 (en) | 1988-01-08 |
| PT85259B (en) | 1990-03-30 |
| ES2021343B3 (en) | 1991-11-01 |
| NL8601767A (en) | 1988-02-01 |
| EP0255964B1 (en) | 1991-04-10 |
| FI872962A0 (en) | 1987-07-03 |
| CA1294555C (en) | 1992-01-21 |
| PT85259A (en) | 1987-08-01 |
| AU594165B2 (en) | 1990-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USRE33845E (en) | Novel skin tanning composition | |
| JP2881748B2 (en) | Hair treatment formulation containing natural ingredients | |
| US4617390A (en) | S-triazine derivatives | |
| DE69732977T2 (en) | STABILIZED ASCORBYL COMPOSITIONS | |
| US4278657A (en) | Creamy or milky skin cosmetic compositions containing natural materials as emulsifying agents | |
| US5032408A (en) | Composition for treatment of skin affections and process for its preparation | |
| JPS59500129A (en) | Sebum-inhibiting cosmetic agent containing long-chain alkanol and antioxidant | |
| KR930000042B1 (en) | Hair cosmetic composition | |
| KR900000071A (en) | Perfume composition in continuous aqueous phase with high concentration of incense | |
| US3186912A (en) | Cosmetic emulsion | |
| DE3045914A1 (en) | ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF ELASTIC LIQUID PLASTERS | |
| EP0138262B1 (en) | Composition for treatment of skin affections and its application | |
| EP0058887A1 (en) | Antifungal compositions with a higher rate of the drug release as a stick | |
| JPH04312519A (en) | Composition for imparting natural suntan color | |
| JP2949442B2 (en) | Emulsified cosmetic | |
| US2340776A (en) | Topical epithelial anesthetic | |
| WO1997026917A1 (en) | Composition for treating skin affections and process for its preparation | |
| JP2932659B2 (en) | Liquid composition | |
| EP0380940B1 (en) | Aqueous skin tanning composition | |
| JP3174421B2 (en) | Liquid softener composition | |
| JPH0899821A (en) | Skin external agent | |
| RU2119329C1 (en) | Base for repellent creams | |
| JP4133639B2 (en) | Hair nourishing composition | |
| JPS627886B2 (en) | ||
| EP0128459A2 (en) | Antimycotic composition for a unique gynaecological treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |